These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 32477347)

  • 21. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
    Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
    J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
    van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
    J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.
    Park JJ; Wong DK; Wahed AS; Lee WM; Feld JJ; Terrault N; Khalili M; Sterling RK; Kowdley KV; Bzowej N; Lau DT; Kim WR; Smith C; Carithers RL; Torrey KW; Keith JW; Levine DL; Traum D; Ho S; Valiga ME; Johnson GS; Doo E; Lok AS; Chang KM;
    Gastroenterology; 2016 Mar; 150(3):684-695.e5. PubMed ID: 26684441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles.
    Ilyinskii PO; Roy CJ; LePrevost J; Rizzo GL; Kishimoto TK
    Front Immunol; 2021; 12():637469. PubMed ID: 34113339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Hepatitis B Virus Negatively Impacts the Protective Immune Crosstalk Between Natural Killer and Dendritic Cells.
    De Pasquale C; Campana S; Barberi C; Sidoti Migliore G; Oliveri D; Lanza M; Musolino C; Raimondo G; Ferrone S; Pollicino T; Ferlazzo G
    Hepatology; 2021 Aug; 74(2):550-565. PubMed ID: 33482027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function.
    Boltjes A; van Montfoort N; Biesta PJ; Op den Brouw ML; Kwekkeboom J; van der Laan LJ; Janssen HL; Boonstra A; Woltman AM
    J Infect Dis; 2015 Apr; 211(8):1268-78. PubMed ID: 25362194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus.
    Chen S; Akbar SM; Abe M; Hiasa Y; Onji M
    Clin Exp Immunol; 2011 Oct; 166(1):134-42. PubMed ID: 21762128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kupffer Cells Support Hepatitis B Virus-Mediated CD8+ T Cell Exhaustion via Hepatitis B Core Antigen-TLR2 Interactions in Mice.
    Li M; Sun R; Xu L; Yin W; Chen Y; Zheng X; Lian Z; Wei H; Tian Z
    J Immunol; 2015 Oct; 195(7):3100-9. PubMed ID: 26304988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+CD25+ Regulatory T Cells Inhibit Natural Killer Cell Hepatocytotoxicity of Hepatitis B Virus Transgenic Mice via Membrane-Bound TGF-β and OX40.
    Chen Y; Sun R; Wu X; Cheng M; Wei H; Tian Z
    J Innate Immun; 2016; 8(1):30-42. PubMed ID: 26067079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study.
    Gane E; Verdon DJ; Brooks AE; Gaggar A; Nguyen AH; Subramanian GM; Schwabe C; Dunbar PR
    J Hepatol; 2019 Nov; 71(5):900-907. PubMed ID: 31306680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
    Kakimi K; Guidotti LG; Koezuka Y; Chisari FV
    J Exp Med; 2000 Oct; 192(7):921-30. PubMed ID: 11015434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states.
    Zhang M; Zhou J; Zhao T; Huang G; Tan Y; Tan S; Fu X; Niu W; Meng G; Chen X; Shang X; Liu D; Ni B; Wang L; Wu Y
    J Infect Dis; 2012 Apr; 205(7):1111-20. PubMed ID: 22357657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-35 inhibits HBV antigen-specific IFN-γ-producing CTLs in vitro.
    Li X; Tian L; Dong Y; Zhu Q; Wang Y; Han W; Liu X; Ni Q; Chen Y; Li L
    Clin Sci (Lond); 2015 Sep; 129(5):395-404. PubMed ID: 25869609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HBV and the immune response.
    Ferrari C
    Liver Int; 2015 Jan; 35 Suppl 1():121-8. PubMed ID: 25529097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic expansion of virus-specific CD8
    Wang H; Wu B; Li L; Hu L; Lin J; Jiang C; Cai G; Shen Q
    Cell Immunol; 2017 Jan; 311():36-45. PubMed ID: 27743606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune suppression in chronic hepatitis B infection associated liver disease: A review.
    Li TY; Yang Y; Zhou G; Tu ZK
    World J Gastroenterol; 2019 Jul; 25(27):3527-3537. PubMed ID: 31367154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs.
    Kondo Y; Shimosegawa T
    Int J Mol Sci; 2015 Feb; 16(2):3307-22. PubMed ID: 25654227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.
    Li B; Yan C; Zhu J; Chen X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Jiang W; Fang W
    Front Immunol; 2020; 11():1037. PubMed ID: 32547550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance.
    Yang S; Wang L; Pan W; Bayer W; Thoens C; Heim K; Dittmer U; Timm J; Wang Q; Yu Q; Luo J; Liu Y; Hofmann M; Thimme R; Zhang X; Chen H; Wang H; Feng X; Yang X; Lu Y; Lu M; Yang D; Liu J
    J Hepatol; 2019 Oct; 71(4):685-698. PubMed ID: 31173811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.